Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT02758860




Registration number
NCT02758860
Ethics application status
Date submitted
23/04/2016
Date registered
3/05/2016
Date last updated
18/05/2022

Titles & IDs
Public title
Predictive Value of DICA in the Diverticular Disease of the Colon
Scientific title
Predictive Value of the Diverticular Inflammation and Complication Assessment (DICA) Endoscopic Classification on the Outcome of the Diverticular Disease of the Colon: a Prospective, Multicenter, International Study.
Secondary ID [1] 0 0
DICA Trial
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Colonic Diverticula 0 0
Condition category
Condition code

Intervention/exposure
Study type
Observational [Patient Registry]
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Treatment: Surgery - Colonoscopy

Treatment: Surgery: Colonoscopy
Patients will be submitted to diagnostic colonoscopy
Intervention code [1] 0 0
Treatment: Surgery
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
DICA score and diverticulitis
Timepoint [1] 0 0
3 years
Secondary outcome [1] 0 0
DICA score and surgery
Timepoint [1] 0 0
3 years
Secondary outcome [2] 0 0
DICA score and therapy
Timepoint [2] 0 0
3 years

Eligibility
Key inclusion criteria
* Endoscopic diagnosis of diverticula in the colon
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* • Radiological signs (by abdominal CT or by ultrasounds) of acute diverticulitis (complicated or uncomplicated)

* Inflammatory bowel diseases;
* Ischemic colitis;
* Prior colonic resection
* Patients with severe liver failure (Child-Pugh C);
* Patients with severe kidney failure;
* Pregnant women;
* Women of childbearing potential not using a highly effective method of contraception;
* Patients who are currently using or who have received any laxative agents < 2 weeks prior to the enrollment;
* Patients who are currently using or who have received mesalamine compounds < 2 weeks prior to the enrollment;
* Patients who are currently using or who have received any probiotic agents < 2 weeks prior to the enrollment;
* Nonsteroidal anti-inflammatory drug (NSAID) use < 1 week prior to the enrollment;
* Patients who have received treatment with antibiotics (even those not absorbed) < 2 weeks prior to the enrollment;
* Inability to comply with study protocol and to give informed consensus to the procedure;
* Patients with or history of cancer, of any origin, within 5 years before enrollment
* History of alcohol, drug, or chemical abuse
* Any severe pathological condition that may interfere with the proper study execution.

Study design
Purpose
Duration
Selection
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/06/2016
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/09/2020
Sample size
Target
Accrual to date
Final
2215
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 0 0
Chris O'Brien Lifehouse - Camperdown
Recruitment postcode(s) [1] 0 0
2050 - Camperdown
Recruitment outside Australia
Country [1] 0 0
Brazil
State/province [1] 0 0
Goiás

Funding & Sponsors
Primary sponsor type
Other
Name
University of Roma La Sapienza
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Antonio Tursi, MD
Address 0 0
Gastroenterology Service , ASL BAT, Andria (BT) - Italy
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.

Results not provided in https://clinicaltrials.gov/study/NCT02758860